A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Systemic Sclerosis · Idiopathic Inflammatory Myopathies · Antineutrophil Cytoplasmic Antibody-Associated Vasculitis · Rheumatoid Arthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Nkarta Investigational Site, Orange, California, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Gainesville, Florida, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Miami, Florida, United States

  • Nkarta Investigational Site, Plantation, Florida, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Chicago, Illinois, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Fairway, Kansas, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Hackensack, New Jersey, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Summit, New Jersey, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, New York, New York, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Stony Brook, New York, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Syracuse, New York, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Dallas, Texas, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Houston, Texas, United States

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Melbourne, Victoria, Australia

    Contact: Study coordinator (Nkarta Central Contact)
  • Nkarta Investigational Site, Manati, Puerto Rico

    Contact: Study coordinator (Nkarta Central Contact)
Study leads
  • Nkarta Study Director

    Study Director

    Nkarta, Inc.